CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Restricted share units	Proportionate Voting Shares	Common Shares	Common Shares Restricted share units	Additional Paid-in Capital	Additional Paid-in Capital Restricted share units	Accumulated Deficit
Balance (in shares) at Dec. 31, 2020			81,177	107,060,237
Balance at Dec. 31, 2020	$ 254,242			$ 1		$ 305,133		$ (50,892)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)				8,261
Exercise of stock options	30					30
Conversion to common shares (in shares)			(3,961)	1,584,410
Common shares issued upon vesting of restricted share units, net of withholding (in shares)				61,548
Common shares issued upon vesting of restricted share units, net of withholding	(112)					(112)
Exercise of common stock warrants (in shares)				98,788
Exercise of common stock warrants	441					441
Harmony Hemp contingent equity compensation (in shares)				169,046
Harmony Hemp contingent equity compensation	360					360
Share-based compensation	832					832
Net loss	(12,774)							(12,774)
Balance (in shares) at Mar. 31, 2021			77,216	108,982,290
Balance at Mar. 31, 2021	243,019			$ 1		306,684		(63,666)
Balance (in shares) at Dec. 31, 2020			81,177	107,060,237
Balance at Dec. 31, 2020	254,242			$ 1		305,133		(50,892)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(19,474)
Balance (in shares) at Sep. 30, 2021			37,214	126,290,058
Balance at Sep. 30, 2021	241,981			$ 1		312,346		(70,366)
Balance (in shares) at Mar. 31, 2021			77,216	108,982,290
Balance at Mar. 31, 2021	243,019			$ 1		306,684		(63,666)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion to common shares (in shares)			(1,327)	530,900
Common shares issued upon vesting of restricted share units, net of withholding (in shares)				16,559
Common shares issued upon vesting of restricted share units, net of withholding	(26)					(26)
Harmony Hemp contingent equity compensation	363					363
ATM program issuance costs (in shares)				278,200
ATM program issuance costs	839					839
Share-based compensation	994					994
Net loss	(5,923)							(5,923)
Balance (in shares) at Jun. 30, 2021			75,889	109,807,949
Balance at Jun. 30, 2021	239,266			$ 1		308,854		(69,589)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion to common shares (in shares)			(38,675)	15,469,990
Common shares issued upon vesting of restricted share units, net of withholding (in shares)				103,074
Common shares issued upon vesting of restricted share units, net of withholding	(5)					(5)
Harmony Hemp contingent equity compensation (in shares)				169,045
Harmony Hemp contingent equity compensation	196					196
ATM program issuance costs (in shares)				740,000
ATM program issuance costs	1,918					1,918
Share-based compensation	1,383					1,383
Net loss	(777)							(777)
Balance (in shares) at Sep. 30, 2021			37,214	126,290,058
Balance at Sep. 30, 2021	241,981			$ 1		312,346		(70,366)
Balance (in shares) at Dec. 31, 2021			0	144,659,964
Balance at Dec. 31, 2021	130,446			$ 1		319,059		(188,614)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares issued upon vesting of restricted share units, net of withholding (in shares)					77,193
Common shares issued upon vesting of restricted share units, net of withholding		$ (45)					$ (45)
Harmony Hemp contingent equity compensation (in shares)				169,045
Harmony Hemp contingent equity compensation	165					165
ATM program issuance costs (in shares)				239,500
ATM program issuance costs	(2)					(2)
Share-based compensation	1,214					1,214
Net loss	(8,626)							(8,626)
Balance (in shares) at Mar. 31, 2022			0	145,145,702
Balance at Mar. 31, 2022	123,152			$ 1		320,391		(197,240)
Balance (in shares) at Dec. 31, 2021			0	144,659,964
Balance at Dec. 31, 2021	$ 130,446			$ 1		319,059		(188,614)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	0
Net loss	$ (24,084)
Balance (in shares) at Sep. 30, 2022			0	145,509,372
Balance at Sep. 30, 2022	108,862			$ 1		321,559		(212,698)
Balance (in shares) at Mar. 31, 2022			0	145,145,702
Balance at Mar. 31, 2022	123,152			$ 1		320,391		(197,240)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares issued upon vesting of restricted share units, net of withholding (in shares)					132,463
Common shares issued upon vesting of restricted share units, net of withholding		(13)					(13)
Share-based compensation	643					643
Net loss	(7,870)							(7,870)
Balance (in shares) at Jun. 30, 2022			0	145,278,165
Balance at Jun. 30, 2022	115,912			$ 1		321,021		(205,110)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares issued upon vesting of restricted share units, net of withholding (in shares)					231,207
Common shares issued upon vesting of restricted share units, net of withholding		$ (67)					$ (67)
ATM program issuance costs	(59)					(59)
Share-based compensation	664					664
Net loss	(7,588)							(7,588)
Balance (in shares) at Sep. 30, 2022			0	145,509,372
Balance at Sep. 30, 2022	$ 108,862			$ 1		$ 321,559		$ (212,698)